Breaking News

You are here » Indian-Commodity  :  Commodities  :  Chana  :  Chana futures trade higher on bargain-buying

19-Jul2014

Chana futures trade higher on bargain-buying

Chana futures traded higher on NCDEX on bargain-buying and on the expectations of improved demand at the spot markets. However, higher supplies from the major producing belts capped some gains in chana prices to some extent.

The contract for August delivery was trading at Rs 2890.00, up by 0.49% or Rs 14.00 from its previous closing of Rs 2876.00. The open interest of the contract stood at 158510 lots.

The contract for September delivery was trading at Rs 2968.00, up by 0.20% or Rs 6.00 from its previous closing of Rs 2962.00. The open interest of the contract stood at 38440 lots on NCDEX.


Related News

View all news

Government imposes 30% import duty on Chana, Masoor

Government has decided to impose 30% import duty on Chana (Chickpeas) and Masoor (Lentils), with immediate effect. The production of Chana (Chickpeas) and Masoor (Lentils) are expected to be high during......

NCDEX reports Rs 91 crore turnover in chana contract on re-launch day

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange has registered a turnover of Rs 91 crore on the first day of the re-launch of chana (pulses) contracts. The......

NCDEX receives SEBI's nod to re-launch chana futures

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange will re-launch the chana futures contract expiring in the months of September 2017, October 2017 and November......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......